Uploaded and Shared in Youtube by:hkllp The manufacturers of thiazolidinedione drugs have strengthened warnings about the risks of heart failure with these medications, which are use to treat type 2 diabetes. They are sold as Avandia (rosiglitazone maleate), Avandaryl (rosiglitazone maleate and glimepiride), and Avandamet (rosiglitazone maleate and metformin hydrochloride), which all contain rosiglitazone, and Actos (pioglitazone hydrochloride), Duetact (pioglitazone hydrochloride and glimepride) and Actoplus met, which all contain pioglitazone. The drug labels already had information about heart failure risk, but now there is a new boxed warning that re-emphasizes that these drugs may cause or worsen heart failure in certain patients, and stresses the importance of carefully monitoring patients for signs of heart failure. If you have been injured after using Avandia, contact the law office of Hissey Kientz by visiting us online at http://www.hkllp.com/, or by emailing at info@hkllp.com.

WHAT IS SYMPOSIER?
Symposier.com is the technological platform that will allow you (and your colleagues) to share medical information, event calendars, clinical cases, new procedures and much more with medicine professionals around the world.
Get in touch with medical professionals around the world and seize the collective experiences and knowledge to the benefit of your own patients.
Establish common-interest groups to build a collaboration network
Learn, comment and publish about local or international medical events
Seize and publish to our video, image and medical documents library

Symposier uploaded this video.
Stronger Warnings about Heart Failure for Certain Diabetes Drugs
Date: 03 Dec 2009
Uploader: Symposier
Lenght: 1m 29s
Specialty:
Cardiology
Internal Medicine
Pharmacology







